Jan Wald
Jan Wald
bid learnt sensitive
It's still a possibility. But the valuation is high, and one thing we learnt from the J&J bid for Guidant is they are very sensitive to valuation.
bid learned sensitive
It's still a possibility. But the valuation is high, and one thing we learned from the J&J bid for Guidant is they are very sensitive to valuation.
They were being nickel-and-dimed by J&J. They had to get out of that loop.
acid might passed test
They might have passed the acid test of being too big.
earnings interest investor renew report
There was nothing in the earnings report that would renew investor interest.
among employees
There's a lot of frustration among institutional shareholders and employees who own the stock.
asked certainly noise questions raised
After all the noise they made, there would certainly be a lot of questions asked (if they raised their bid).
certainly company
I certainly think it could be a stand-alone company. I'm not certain it should be.
employees minnesota risk
I don't think there's much risk to employees ? especially the Minnesota contingent.
boston less time worse
The less time they give Boston Scientific, the worse it is for Boston Scientific. They have less time to react.
johnson stronger threat
The combination of Guidant and Johnson & Johnson is a stronger threat to Medtronic,
beginning fourth looked looking quarter
The end of the fourth quarter looked better than the beginning, and 2006 is looking OK.
actions louder speak
This is one of those times when actions speak louder than words.